In a non-public letter sent earlier this week, the US Department of Health and Human Services (HHS) recommended to the US Drug Enforcement Administration (DEA) that marijuana be re-classified
Continue Reading HHS to DEA: Marijuana Should Be Schedule III – What This Means for The Cannabis Industry
We’ve written previously about FDA’s denial of three petitions requesting that the agency issue a regulation that would allow cannabidiol (CBD) products to be marketed as dietary supplements. FDA
Continue Reading Two hemp-derived CBD bills are re-introduced despite FDA’s call for a different legislative fixThe House has passed a revised version of the Medical Marijuana and Cannabidiol Research Expansion Act, HR 8454, sending it back to the Senate for action. With previous bipartisan
Continue Reading A Green Light for Canna-Research? Medical Marijuana and CBD Research Bill on the Cusp
The US Hemp Production Handbook offers a high-level, concise overview of the basic rules and regulations for producing hemp in the United States.
Continue Reading The US Hemp Production Handbook
